Group 1 - The core viewpoint of the report is that the overall valuation of A-shares is relatively reasonable and not overvalued [1] - As of November 4, 2025, the P/E TTM of the CSI 300 is approximately 14.2 times, compared to 25.5 times for the S&P 500, 23.8 times for the Nikkei 225, 19.3 times for the French CAC 40, 17.4 times for the MSCI Asia-Pacific, and 17.2 times for the German DAX, indicating that A-share valuations remain low in an international comparison [1] - The current dividend yield of the CSI 300 is about 2.5%, which is attractive compared to the approximately 1.8% yield of ten-year government bonds [1] - The market capitalization of A-shares relative to China's GDP is about 77%, which is low compared to other major global markets, such as approximately 230% for the U.S. and 180% for Japan [1] - The total market capitalization of A-shares to M2 ratio is approximately 35.6%, close to the historical average of 35.7%, suggesting a "repair" in valuation rather than overvaluation [1] Group 2 - The report indicates that Chinese stock assets face a historical opportunity due to the global monetary system's restructuring, with asset revaluation potentially still in its early stages [2] - The restructuring of the global monetary order may prompt global funds to reallocate in two ways: diversification, where investors seek alternatives to the U.S. dollar, and fragmentation, where previously globally allocated funds return to their respective markets [2] - If policies are appropriately addressed, the international status of the renminbi is expected to improve, and renminbi assets may benefit from the global fund reallocation [2] - The forces of the global monetary order's restructuring and the resulting changes in capital flows may outweigh the fundamental strengths of any single country or market [2]

Group 1: Market Opening and Investment Opportunities - The Shanghai Stock Exchange (SSE) is committed to creating a more open and inclusive market ecosystem, expanding cross-border investment opportunities for global investors [1][2] - The China Securities Regulatory Commission (CSRC) emphasizes the steady expansion of high-level institutional opening in the capital market, aiming to create a favorable investment environment for international investors [1][3] - Global asset management firms express increasing confidence in the long-term value of investing in China, driven by a stable macroeconomic environment and ongoing policy optimization [1][2] Group 2: Capital Market Reforms - The "15th Five-Year Plan" suggests a steady expansion of institutional opening, providing guidance for capital market cooperation [2] - The CSRC plans to deepen comprehensive reforms in investment and financing, enhancing the inclusiveness and adaptability of capital market systems [2][4] - The SSE aims to optimize key systems related to issuance, refinancing, and mergers and acquisitions to guide capital towards advanced technologies and future industries [4] Group 3: Mergers and Acquisitions (M&A) Trends - The A-share market has entered a new active cycle for mergers and acquisitions, with over 1,000 disclosed transactions since the release of new M&A reform opinions [5] - M&A activities reflect profound changes in China's economic development dynamics, with emerging industries accelerating their layout through acquisitions [5][6] - International investors are presented with new opportunities in the M&A market, particularly in technology and advanced manufacturing sectors [6][7] Group 4: Long-term Capital Investment Strategies - Long-term capital is increasingly being allocated to equity assets, with a focus on high-dividend assets in a low-interest-rate environment [9][10] - The importance of maintaining a long-term investment perspective is emphasized, particularly in the context of high volatility in technology stocks [9][10] - The need for a systematic approach to enhance the integration of long-term capital into the market is highlighted, including improving the stability of dividend mechanisms among listed companies [10][11] Group 5: Future Outlook - Experts predict that China's stock market is attractive for long-term investors, driven by manufacturing, innovation, and talent [11] - The capital market is expected to enter a golden development period amid ongoing reforms and innovations [11] - Current conditions present a significant opportunity for strategic investments in China's high-quality development [11]

Core Points - Shanghai Rendu Biotechnology Co., Ltd. announced a change in its continuous supervision sponsor representative due to the work relocation of the original representative [2] - China International Capital Corporation (CICC) is the sponsor for the company's initial public offering (IPO) and listing on the Sci-Tech Innovation Board, with the continuous supervision period lasting until December 31, 2025 [2] - Yang Wei has been appointed as the new sponsor representative to ensure the orderly continuation of supervision work [2]

Core Viewpoint - China International Capital Corporation (CICC) announced the issuance of perpetual subordinated bonds aimed at professional investors, with a total issuance size of up to RMB 3 billion, including RMB 3 billion [1] Group 1 - The first phase of the bond issuance has a final coupon rate set at 2.23% based on the results of the offline investor inquiry [1]

格隆汇11月12日丨中金公司(03908.HK)公告，中国国际金融股份有限公司面向专业投资者公开发行不超 过200亿元(含200亿元)永续次级债券已获得中国证券监督管理委员会《关于同意中国国际金融股份有限 公司向专业投资者公开发行永续次级公司债券注册的批复》(证监许可【2025】2290号)。本次债券由华 泰联合证券有限责任公司和兴业证券股份有限公司承销，其中中国国际金融股份有限公司2025年面向专 业投资者公开发行永续次级债券(第一期)(以下简称"本期债券")发行规模为不超过人民币30亿元(含30亿 元)。本期债券票面利率询价区间为1.70%-2.70%。本期债券票面利率将根据网下询价簿记结果，由簿记 管理人按照国家有关规定协商一致在利率询价区间内确定。 2025年11月12日，主承销商在网下向投资者进行了票面利率询价。根据网下投资者询价结果，最终确定 本期债券的票面利率为2.23%。 ...

Group 1 - The company, China International Capital Corporation (CICC), announced the issuance of perpetual subordinated bonds aimed at professional investors, with a total issuance size not exceeding RMB 3 billion (including RMB 3 billion) [1] - The final coupon rate for this bond issuance was determined to be 2.23% based on the results of the offline investor inquiry [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 China International Capital Corporation Limited 中 國 國 際 金 融 股 份 有 限 公 司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：03908） 海外監管公告 本公告乃根據香港聯合交易所有限公司證券上市規則第13.10B條而作出。 茲載列中國國際金融股份有限公司（「本公司」）在上海證券交易所網站刊登的本公司2025 年面向專業投資者公開發行永續次級債券（第一期）票面利率公告，僅供參閱。 承董事會命 中國國際金融股份有限公司 董事會秘書 孫男 中國，北京 2025年11月12日 於本公告日期，本公司執行董事為陳亮先生及王曙光先生；非執行董事為張薇女士、 孔令岩先生及田汀女士；以及獨立非執行董事為吳港平先生、陸正飛先生、彼得 • 諾蘭先 生及周禹先生。 中国国际金融股份有限公司 2025 年面向专业投资者公开发行永 续次级债券（第一期）票面 ...

Core Viewpoint - The new strategic investment regulations create favorable conditions for both Chinese companies going abroad and foreign companies entering China, enhancing cross-border mergers and acquisitions [1] Group 1: Strategic Investment Regulations - The new regulations, titled "Management Measures for Strategic Investment by Foreign Investors in Listed Companies," facilitate cross-border equity swaps, making it easier for Chinese companies to engage in deeper cross-border industrial cooperation [1] - The implementation of the new regulations is expected to benefit Chinese companies in finding foreign partners for joint acquisitions and developments, allowing foreign partners to gain liquidity through equity swaps at the listed company level [1] Group 2: Cross-Border M&A Trends - Historically, the company's M&A business has been evenly split between domestic and cross-border transactions, with cash being the primary payment method for cross-border projects [1] - The shift towards more convenient cross-border equity swaps is anticipated to enhance the attractiveness of cross-border collaborations for Chinese enterprises [1]

Core Insights - The Shanghai Stock Exchange International Investor Conference was held on November 12-13, highlighting new favorable conditions for both Chinese companies going abroad and foreign companies entering China due to the new strategic investment regulations [1] Group 1: Strategic Investment Regulations - The new strategic investment regulations ("Management Measures for Foreign Investors' Strategic Investment in Listed Companies") create more favorable conditions for cross-border investments [1] - The implementation of the new regulations facilitates cross-border share swaps, enhancing deeper cross-border industrial cooperation for Chinese companies [1] Group 2: M&A Business Insights - The head of the M&A business at CICC, Chen Jie, noted that historically, the firm's M&A business was split evenly between domestic and cross-border projects, with cash being the primary payment method for cross-border deals [1] - The new regulations allow foreign partners to participate in joint acquisitions and developments, enabling them to convert equity into liquidity at the listed company level, which is beneficial for Chinese companies seeking foreign partners [1]

Core Insights - The three major stock indices experienced a slight decline on November 12, with the pharmaceutical sector showing strength, particularly with stocks like Yaoyigou hitting the daily limit and Jianfa Zhixin rising over 10% [2] Industry Summary - The National Disease Control and Prevention Administration held a press conference on November 10 regarding the prevention and control of acute respiratory infectious diseases during the autumn and winter seasons. Monitoring data indicates that flu activity in China is currently on the rise, with the H3N2 subtype accounting for over 95% of cases [2] - The China Securities Journal reports that the trend of innovation going global is clear, with the pharmaceutical sector leading the way. The ongoing reform in drug review processes is yielding benefits, and the Chinese innovative drug industry has entered a 2.0 era, shifting from "import imitation" to "innovation output" [2] - The report highlights that the development of innovative drugs is supported by improved investment and financing data, indicating a new cycle for CXO and upstream sectors. The potential for medical devices and other categories to also expand internationally is promising [2]